By: Joseph Jamil of Minden Gross LLP The Access to Cannabis for Medical Purposes Regulations (“ACMPR”), as it is drafted does not contain any restrictions as to where medical patients may consume cannabis. On the Provincial level, Ontario has not set any restrictions either. In November 2015, the Ontario government attempted to amend the Electronic Cigarette Act and the … [Read more...] about Ontarians Can Use Medical Cannabis in Public
Senate Bill S-230, also known as the Drug-Impaired Driving Detection act ("DIDDA") was first introduced in the Canadian Senate in October, 2016 and was put through its First Reading in the House of Commons on February 9, 2017. Yesterday, at its second reading at the House of Commons, the Bill was defeated. DIDDA would have amended the Criminal Code to allow use of roadside … [Read more...] about Senate Bill S-230 Defeated at Second Reading in the House of Commons
By: Andrew Elbaz, Alexandra (Sasha) Toten, and Joseph Jamil of Minden Gross LLP The Ontario Securities Commission (“OSC”) first signaled that it considers diversity on public company boards and executive teams to be a priority when it implemented what is known as the women on boards and in executive positions rules (the “WB/EP Rules”) in 2014. At a roundtable discussion on … [Read more...] about If you’re listed on the TSX, you may have to set targets for gender diversity
Last week, New Brunswick Liquor (“NB Liquor”) issued a tender for locations to sell recreational cannabis. This morning we learned that these storefronts will house stand-alone recreational cannabis retail outlets, which will operate as subsidiaries of NB Liquor. The stores will be coupled with online sales that will either deliver to customer homes or allow orders to be … [Read more...] about New Brunswick Announces Retail Model for Recreational Cannabis
By: Andrew Elbaz, Alexandra (Sasha) Toten, and Joseph Jamil of Minden Gross LLP On October 16, 2017, the Canadian Securities Administrators (“CSA”) set out specific disclosure expectations for issuers that currently have or are in the process of developing cannabis-related activities in the U.S. (“U.S.-Related Cannabis Issuers”). The CSA Staff Notice 51-352 Issuers with U.S. … [Read more...] about CSA announces disclosure expectations for cannabis companies operating in the U.S.